Clinical trial · Observational
Photodynamic Therapy (PDT) Oncology Registry
NCT01842555CI-TRIAL-00034567PDT RegistryunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The data elements for the PDT Registry project include virtually all the elements in the standard hospital-based cancer registry record, although in some cases at a finer level of detail. All data points should be found in the participant's medical record. The principal difference between the PDT Registry data set and that collected by the registries is the inclusion of more information specific to PDT.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal | — | UNRESOLVED | — |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Registry | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- PDT registry patients
- description
- Any newly diagnosed lung or esophageal cancer that is being being treated with PDT at a participating institution.
- interventionNames
- Other: Registry
Primary outcomes (1)
- measure
- A Photodynamic Therapy (PDT) research repository and de-identified registry
- timeFrame
- Up to 3 years
- description
- Participating sites will be able to utilize aggregate, de-identified data to perform research on PDT, the patients receiving PDT, and their outcomes and complications after the procedure. Data collected includes the following: Table 1. Outline of Data Elements in the PDT Registry 1. Patient Visit Form- Demographics Patient Identification Number Institution Number Study Type Surgeon ID Date of Birth Age at PDT Racial Background Gender Tobacco Use Alcohol Use Vital Status 2. Pre-Treatment Primary Site Clinical Sta
Secondary outcomes (3)
- measure
- Survival following palliative and non-palliative PDT
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 18 years of age or older, male or female, diagnosed with cancer and is undergoing or has undergone Photodynamic Therapy (PDT). * Patients must have undergone PDT with Photofrin® at a participating institution. * Patients scheduled to undergo PDT with Photofrin® * Cancer patients receiving some or all primary care (e.g.,cancer-directed surgery, systemic therapy, radiation therapy, palliative care)in the participating institution. * Cancer patients with a history of any type of cancer who have been no evidence of disease(for five years but without a history of distant metastases or evidence of relapse if they meet the previous criteria). Exclusion Criteria: * Cancer patients who present to the participating institution with a diagnosis of a simultaneous second primary. * Cancer patients receiving all primary cancer care (e.g., cancer-directed surgery, chemotherapy, targeted therapy, radiation therapy, palliative care) outside of participating institution. * Patients treated with photosensitizers other than Photofrin®
References
Publications (0)
Data not yet available
No reference posted for this study.